Study of factors that affect warfarin treatment
Treatments studied
This study looks at why some people process warfarin (a blood-thinning medicine) differently. It aims to learn what personal or medication factors may affect how well warfarin works, so future dosing can be safer and more accurate.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 20 and 50 years old
- Have no major or significant health problems
- Do not have an allergy to warfarin or phenytoin
- Do not have an allergy to penicillin or cephalosporin antibiotics (including dicloxacillin)
- Do not take regular medicines, including birth control pills
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the medicine PF-07328948 is processed by people with different levels of liver function. It includes both healthy people and those with stable liver disease (classified as mild, moderate, or severe). The goal is to see if the liver condition affects how the drug works in the body.
This study looks at how well warfarin (a blood thinner) works and is taken by people who have both rheumatic heart disease and atrial fibrillation. It aims to improve treatment safety and outcomes for this condition.
This study tests a better way to manage warfarin (a blood thinner) for people with atrial fibrillation (an irregular heartbeat). The goal is to improve treatment and help prevent stroke.
This study tests a new way to monitor and adjust warfarin (a blood thinner) using a simple bedside test, aiming to make dosing more precise. Participation may help you get faster and more personalized dose adjustments while you are in the hospital.
This study checks whether giving community pharmacists information about your kidney function when they fill your blood-thinner prescription can help reduce bleeding problems. If you take a direct oral anticoagulant (like apixaban or rivaroxaban), your participation could help improve how these medicines are managed safely.
This study looks at how blood-thinning medications (like aspirin and clopidogrel) work in people with hardened arteries or peripheral artery disease (PAD). By understanding this, doctors hope to improve treatment and prevent heart attacks and strokes.
Hear when a new Healthy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.